PRTODAY / NewswireToday Free press release distribution service network

More news: Nanotechnology
Written by / Agency / Source: Nanowerk, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Nanocarriers Could Become an Alternative to Brain Surgery - If you had brain tumor, would you rather receive your medicine through an injection in the arm or have a hole drilled in your skull? One of the most important applications of nanotechnology could be drug delivery, e.g. to the brain.
Nanocarriers Could Become an Alternative to Brain Surgery

 

NewswireToday - /newswire/ - Honolulu, HI, United States, 2006/03/13 - If you had brain tumor, would you rather receive your medicine through an injection in the arm or have a hole drilled in your skull? One of the most important applications of nanotechnology could be drug delivery, e.g. to the brain..

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Nanotechnology Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

(Nanowerk News) An international group of researchers developed a novel targeted nanoparticulate drug delivery system for the brain.
The lead author of the study, Patrick Couvreur, director of the Center for Pharamceutical Studies at the Université Paris Sud explained to Nanowerk: "The delivery of peptides into the brain is a challenge that is not adressed with classical pharmaceutical formulations, since the blood brain barrier doesn't allow the easy diffusion of such molecules."

A tight seal of endothelial cells lines the blood vessels in the brain and acts as a barrier to protect its cells. This is known as the blood-brain barrier (BBB). BBB strictly limits transport into the brain through both physical (tight junctions) and metabolic (enzymes) barriers and keeps most substances, such as chemicals and large biomolecules, out of the brain.
The challenge in treating most brain disorders is overcoming the difficulty of delivering therapeutic agents to specific regions of the brain by crossing the BBB. The problem is the BBB does not differentiate what it keeps out. With very few exceptions, only nonionic and low molecular weight molecules soluble in fat clear the BBB. For instance, alcohol, caffeine, nicotine and antidepressants meet these criteria. However, large molecules needed to deliver drugs cannot cross it.
The development of carrier nanoparticles, as done by this research group, is therefore an important step towards detection and therapeutic treatment of diseases in the brain. BBB investigation is an ever growing and dynamic field studied by pharmacologists, neuroscientists, pathologists, physiologists, and clinical practitioners.

"The chitosan-based immuno-nanoparticles we have developed" says Couvreur "allow transport across the BBB by combining two factors: 1) the ability of cationic (with a full positive charge) chitosan to interact with the negative charges of the brain endothelium and 2) the affinity of the monoclonal antibody OX26 for the transferrin receptor."

The researchers hypothized that transferrin receptor (TfR), which is highly concentrated in the BBB, may trigger receptor-mediated transport across the BBB. Transferrin itself is limited as a brain drug transport vector since the transferrin receptors are almost saturated under physiologic conditions. However, the antibodies that bind to TfR have been shown to selectively target BBB endothelium due to the high levels of TfR expressed by these cells. Therefore, these antibodies are potential carriers for the delivery of therapeutic agents to the central nervous systems. In particular, a mouse monoclonal antibody, OX26, with a high abundance of transferrin receptors at the brain microvascular endothelium has been detected and was used in the experiments.
Consequently, the researchers designed chitosan (CS) nanospheres conjugated with poly(ethylene glycol) (PEG) bearing the OX26 monoclonal antibody. The nanoparticles were injected intravenously to mice. The results showed that an important amount of nanoparticles were located in the brain.

These findings, which were also confirmed by electron microscopic examination of the brain tissue, indicate that this novel targeted nanoparticulate drug delivery system was able to translocate into the brain tissue after intravenous administration.
The research paper is titled "Development and Brain Delivery of Chitosan-PEG Nanoparticles Functionalized with the Monoclonal Antibody OX26" and was published in the October 20, 2005 online edition of Bioconjugate Chemistry.

By Michael Berger, Copyright 2006 Nanowerk LLC

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Nanotechnology Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Nanowerk, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Nanotechnology articles,
CATCH Visitors via Your Competitors Announcements!


Nanocarriers Could Become an Alternative to Brain Surgery

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Michael Berger - Nanowerk.com 
1-808-741-1739 michael[.]nanowerk.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Nanowerk, LLC securities in any jurisdiction including any other companies listed or named in this release.

Nanotechnology via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Nanowerk, LLC / Company Profile


Read Nanotechnology Most Recent Related Newswires:

NEC Discovers 'Carbon Nanobrush' - The World's First Fibrous Aggregate of Carbon Nanohorns
Frost & Sullivan Commends RUSNANO for Accelerating the Russian Nanotechnology Industry with Its Unique Investment Strategy and Innovative Services
Imec and Crystal Solar Demonstrate 22.5 Percent nPERT Si Solar Cells on Kerfless Epitaxial Wafers
Nanomaterials for Printing Market Worth $1,974 Million by 2019 Reports MarketsAndMarkets
Nanotechnology in Medical Devices Market Worth $8.5 Billion by 2019 Finds MarketsandMarkets
Polymer Nanocomposites Market Worth $5,100 Million by 2020 Finds MarketsAndMarkets
First Speakers of EuroNanoForum 2015 Announced
OCSiAl Group Receives Frost & Sullivan Technology Innovation Award for its Game-Changing Carbon Nanotube Production Process
Elmo Features its NANO Ultra High Power Servo Drive at IAS 2014 in China
Carbodeon Ltd Oy Announces Improvements to Electroless Nickel Including A 3x Improvement in Wear Resistance
IMARC Group Publishes New Report Insights on Setting Up A Rare Earth Magnet Manufacturing Plant
Carbodeon Enables 20 Percent Increase in Polymer Thermal Filler Conductivity
Industry Veteran Fergus Clarke Joins Picodeon as CEO
Picodeon’s Pulsed Laser Deposition Technology Enables Microstructural Control
Imec Integrates CCD and CMOS Technology to Improve Performance of CMOS imagers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)